- Home
- AOMR vs NAUT Comparison
AOMR vs NAUT Comparison
Compare AOMR & NAUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AOMR
- NAUT
- Stock Information
- Founded
- AOMR 2018
- NAUT 2016
- Country
- AOMR United States
- NAUT United States
- Employees
- AOMR N/A
- NAUT N/A
- Industry
- AOMR Real Estate Investment Trusts
- NAUT Biotechnology: Laboratory Analytical Instruments
- Sector
- AOMR Real Estate
- NAUT Industrials
- Exchange
- AOMR Nasdaq
- NAUT Nasdaq
- Market Cap
- AOMR 228.8M
- NAUT 188.3M
- IPO Year
- AOMR 2021
- NAUT N/A
- Fundamental
- Price
- AOMR $7.91
- NAUT $0.76
- Analyst Decision
- AOMR Strong Buy
- NAUT Hold
- Analyst Count
- AOMR 5
- NAUT 3
- Target Price
- AOMR $11.60
- NAUT $3.58
- AVG Volume (30 Days)
- AOMR 122.9K
- NAUT 174.6K
- Earning Date
- AOMR 05-06-2025
- NAUT 04-29-2025
- Dividend Yield
- AOMR 16.16%
- NAUT N/A
- EPS Growth
- AOMR N/A
- NAUT N/A
- EPS
- AOMR 1.17
- NAUT N/A
- Revenue
- AOMR $51,458,000.00
- NAUT N/A
- Revenue This Year
- AOMR N/A
- NAUT N/A
- Revenue Next Year
- AOMR $7.33
- NAUT N/A
- P/E Ratio
- AOMR $6.76
- NAUT N/A
- Revenue Growth
- AOMR N/A
- NAUT N/A
- 52 Week Low
- AOMR $7.36
- NAUT $0.66
- 52 Week High
- AOMR $13.32
- NAUT $3.09
- Technical
- Relative Strength Index (RSI)
- AOMR 33.34
- NAUT 38.87
- Support Level
- AOMR $7.36
- NAUT $0.72
- Resistance Level
- AOMR $7.95
- NAUT $0.83
- Average True Range (ATR)
- AOMR 0.38
- NAUT 0.11
- MACD
- AOMR -0.06
- NAUT 0.02
- Stochastic Oscillator
- AOMR 24.07
- NAUT 39.20
About AOMR Angel Oak Mortgage REIT Inc.
Angel Oak Mortgage REIT Inc is a real estate finance company focused on acquiring and investing in the first lien non-QM loans and other mortgage-related assets in the U.S. mortgage market. Its objective is to generate attractive risk-adjusted returns for its stockholders, through cash distributions and capital appreciation, across interest rates and credit cycles.
About NAUT Nautilus Biotechnolgy Inc.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. It has built a prototype of a single-molecule instrument, Proteomic Analysis System.